Nanoparticle-Mediated Therapy with miR-198 Sensitizes Pancreatic Cancer to Gemcitabine Treatment through Downregulation of VCP-Mediated Autophagy
Christian Marin-Muller, Dali Li, Jian-Ming Lü, Zhengdong Liang, Osvaldo Vega-Martínez, Sue E. Crawford, Mary K. Estes, William E. Fisher, Changyi Chen and Qizhi Yao. (2023)
Pharmaceutics 2023, 15(8), 2038; https://doi.org/10.3390/pharmaceutics15082038
MiR-198 sensitizes pancreatic cancer to gemcitabine treatment through downregulation of VCP-mediated autophagy maturation.
Marín-Müller, C., Vega-Martínez, O., Chaves-Martínez, L., Valverde-Hernández, J. C., Zamora-Rodríguez, M., Lu, J. M., Liu, D., Chen, C. & Yao, Q. C. (2022).
Journal of Clinical Oncology, 40:16_suppl, e16290-e162
A novel miR-198-based mimic as a potential therapeutic against pancreatic ductal adenocarcinoma (PDAC).
Marín-Müller, C., Vega-Martínez, O., Chaves-Martínez, L., Valverde-Hernández, J. C., Zamora-Rodríguez, M., Lu, J. M., Liu, D., Chen, C. & Yao, Q. C. (2022).
Journal of Clinical Oncology, 40:16_suppl, e15061-e15061.
Sa1112: Therapeutic potential of miR-198 to suppress MC38 colonic adenocarcinoma growth.
Liu, Y., Kim, J. N., Reno, G. B., Li, J., Vega-Martinez, O., Marín-Müller, C., Heeckt, P & Bauer, A. J. (2022).
Gastroenterology, 162(7), S-310.
Two Antibody-Guided Lactic-co-Glycolic Acid-Polyethylenimine (LGA-PEI) Nanoparticle Delivery Systems for Therapeutic Nucleic Acids.
Lü, J. M., Liang, Z., Liu, D., Zhan, B., Yao, Q., & Chen, C. (2021). Two Antibody-Guided Lactic-co-Glycolic Acid-Polyethylenimine (LGA-PEI) Nanoparticle Delivery Systems for Therapeutic Nucleic Acids.
Pharmaceuticals, 14(9), 841.
New polymer of lactic-co-glycolic acid-modified polyethylenimine for nucleic acid delivery.
Lü, J. M., Liang, Z., Wang, X., Gu, J., Yao, Q., & Chen, C. (2016). New polymer of lactic-co-glycolic acid-modified polyethylenimine for nucleic acid delivery.
Nanomedicine, 11(15), 1971-1991.
A tumorigenic factor interactome connected through tumor suppressor microRNA-198 in human pancreatic cancer.
Marin-Muller, C., Li, D., Bharadwaj, U., Li, M., Chen, C., Hodges, S. E., ... & Yao, Q. (2013). A tumorigenic factor interactome connected through tumor suppressor microRNA-198 in human pancreatic cancer.
Clinical Cancer Research, 19(21), 5901-5913.
Mesothelin confers pancreatic cancer cell resistance to TNF-α-induced apoptosis through Akt/PI3K/NF-κB activation and IL-6/Mcl-1 overexpression.
Bharadwaj, U., Marin-Muller, C., Li, M., Chen, C., & Yao, Q. (2011). Mesothelin confers pancreatic cancer cell resistance to TNF-α-induced apoptosis through Akt/PI3K/NF-κB activation and IL-6/Mcl-1 overexpression.
Molecular cancer, 10(1), 1-14.
Mesothelin overexpression promotes autocrine IL-6/sIL-6R trans-signaling to stimulate pancreatic cancer cell proliferation.
Bharadwaj, U., Marin-Muller, C., Li, M., Chen, C., & Yao, Q. (2011). Mesothelin overexpression promotes autocrine IL-6/sIL-6R trans-signaling to stimulate pancreatic cancer cell proliferation.
Carcinogenesis, 32(7), 1013-1024.
Current advances in research and clinical applications of PLGA-based nanotechnology.
Li, M., Marin-Muller, C., Bharadwaj, U., Chow, K. H., Yao, Q., & Chen, C. (2009). MicroRNAs: control and loss of control in human physiology and disease.
World journal of surgery, 33(4), 667-684.
MicroRNAs: control and loss of control in human physiology and disease.
Lü, J. M., Wang, X., Marin-Muller, C., Wang, H., Lin, P. H., Yao, Q., & Chen, C. (2009). Current advances in research and clinical applications of PLGA-based nanotechnology.
review of molecular diagnostics, 9(4), 325-341.